These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27808434)

  • 1. Force spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers.
    Pires RH; Saraiva MJ; Damas AM; Kellermayer MS
    J Mol Recognit; 2017 Mar; 30(3):. PubMed ID: 27808434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils.
    Pires RH; Karsai Á; Saraiva MJ; Damas AM; Kellermayer MS
    PLoS One; 2012; 7(9):e44992. PubMed ID: 22984597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy.
    Pires RH; Saraiva MJ; Damas AM; Kellermayer MS
    J Mol Recognit; 2011; 24(3):467-76. PubMed ID: 21504025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
    Lindgren M; Sörgjerd K; Hammarström P
    Biophys J; 2005 Jun; 88(6):4200-12. PubMed ID: 15764666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
    Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
    Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoscale structural characterization of transthyretin aggregates formed at different time points of protein aggregation using atomic force microscopy-infrared spectroscopy.
    Rodriguez A; Ali A; Holman AP; Dou T; Zhaliazka K; Kurouski D
    Protein Sci; 2023 Dec; 32(12):e4838. PubMed ID: 37967043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
    J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers.
    Dasari AKR; Hughes RM; Wi S; Hung I; Gan Z; Kelly JW; Lim KH
    Sci Rep; 2019 Jan; 9(1):33. PubMed ID: 30631096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the interfacial regions in misfolded transthyretin oligomers.
    Dasari AKR; Coats MF; Ali AB; Lim KH
    Biochim Biophys Acta Proteins Proteom; 2024 Sep; 1872(5):141027. PubMed ID: 38796131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial conformational changes of human transthyretin under partially denaturing conditions.
    Yang M; Lei M; Bruschweiler R; Huo S
    Biophys J; 2005 Jul; 89(1):433-43. PubMed ID: 15821170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
    Faria TQ; Almeida ZL; Cruz PF; Jesus CS; Castanheira P; Brito RM
    Phys Chem Chem Phys; 2015 Mar; 17(11):7255-63. PubMed ID: 25694367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic Misfolded Transthyretin Oligomers with Different Molecular Conformations Formed through Distinct Oligomerization Pathways.
    Dasari AKR; Yi S; Coats MF; Wi S; Lim KH
    Biochemistry; 2022 Nov; 61(21):2358-2365. PubMed ID: 36219173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cys114-linked dimers of transthyretin are compatible with amyloid formation.
    Karlsson A; Olofsson A; Eneqvist T; Sauer-Eriksson AE
    Biochemistry; 2005 Oct; 44(39):13063-70. PubMed ID: 16185074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers.
    Yang M; Lei M; Huo S
    Protein Sci; 2003 Jun; 12(6):1222-31. PubMed ID: 12761393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequence-dependent unfolding pathway plays a critical role in the amyloidogenicity of transthyretin.
    Yang M; Yordanov B; Levy Y; Brüschweiler R; Huo S
    Biochemistry; 2006 Oct; 45(39):11992-2002. PubMed ID: 17002298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative stabilization of transthyretin by clusterin and diflunisal.
    Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
    Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized structural fluctuations promote amyloidogenic conformations in transthyretin.
    Lim KH; Dyson HJ; Kelly JW; Wright PE
    J Mol Biol; 2013 Mar; 425(6):977-88. PubMed ID: 23318953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils.
    Groenning M; Campos RI; Hirschberg D; Hammarström P; Vestergaard B
    Sci Rep; 2015 Jun; 5():11443. PubMed ID: 26108284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
    Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
    J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.